How Can Big Pharma Make Amends for the Opioid Epidemic? How Can Big Pharma Make Amends for the Opioid Epidemic?
It’s unlikely pharmaceutical executives will face a full reckoning in court, but transformative justice could give victims the relief they deserve.
Nov 22, 2019 / Mattea Kramer
Is the FDA Misleading Congress About the Safety of Imported Medicines? Is the FDA Misleading Congress About the Safety of Imported Medicines?
Prescription drugs can cost 80 percent less in Canada, Australia, and the UK—why isn’t the FDA supporting safe importation?
Apr 1, 2019 / Gabriel Levitt
Forget the Wall—the Opioid Crisis Is Trump’s Real National Emergency Forget the Wall—the Opioid Crisis Is Trump’s Real National Emergency
Opioid overdoses claimed nearly 50,000 American lives in 2017 alone, more than 9/11 and the wars in Iraq and Afghanistan combined.
Jan 31, 2019 / Rajan Menon
The Battle Over NAFTA 2.0 Has Just Begun The Battle Over NAFTA 2.0 Has Just Begun
Progressives must fight strategically to improve it—if they don’t, the consequences could be devastating.
Dec 21, 2018 / Feature / Lori Wallach
Pharmaceutical Giants Have Avoided Paying About $2.3 Billion in Taxes in the US Alone Pharmaceutical Giants Have Avoided Paying About $2.3 Billion in Taxes in the US Alone
Could that money be used to fund a more humane health-care system?
Oct 2, 2018 / Michelle Chen
Can the US Provide a Public Option for Prescription Drugs? Can the US Provide a Public Option for Prescription Drugs?
Patient advocates and health-care experts say the government can get into the generic pharmaceuticals business—and it wouldn’t even require a new law.
Oct 1, 2018 / Joel Dodge and Sean McElwee
The Transatlantic Alliance Will Survive Trump The Transatlantic Alliance Will Survive Trump
The forecasts of its demise are premature. Why? Because there’s a shared interest in global domination.
Aug 27, 2018 / Mark Weisbrot
House Democrats Launch a Challenge to Big Pharma House Democrats Launch a Challenge to Big Pharma
New legislation could mark a significant advance in the fight to bring down drug prices.
Aug 7, 2018 / Richard Eskow
The ‘Right-to-Try’ Unproven Pharmaceuticals Is a Right-Wing Scheme The ‘Right-to-Try’ Unproven Pharmaceuticals Is a Right-Wing Scheme
Proposals to loosen the Food and Drug Administration’s oversight of experimental drugs sound compassionate—but there’s little evidence they’ll help patients.
Feb 12, 2018 / Zoë Carpenter
These Pharmaceutical Companies Are Making a Killing Off the Opioid Crisis These Pharmaceutical Companies Are Making a Killing Off the Opioid Crisis
Why do the manufacturers of naloxone, the life-saving overdose antidote, keep hiking the price?
Dec 15, 2017 / Daniel Denvir